IPP Bureau
Novo Nordisk to showcase late-stage pipeline & semaglutide expansion at ADA 2026
By IPP Bureau - May 28, 2026
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
Supriya Lifescience posts 50% revenue growth in Q4 FY26; PAT rises to Rs 74 crore
By IPP Bureau - May 28, 2026
On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25
Lupin’s Ankleshwar facility receives EIR from U.S. FDA
By IPP Bureau - May 28, 2026
The Establishment Inspection Report came following closure of a product- specific pre-approval inspection from March 2 to March 7, 2026
Organ Man of India Nilesh Mandlewala bestowed with Padma Shri
By IPP Bureau - May 28, 2026
Honoured for his immense contribution in the field of social service and organ donation awareness
India’s healthcare spending triples to Rs 3.85 lakh crore over the last decade
By IPP Bureau - May 28, 2026
As per National Health Accounts (NHA) estimates, government health expenditure rose steadily between 2013-14 and 2022-23, while out-of-pocket spending declined significantly
Kyoto–Tokyo consortium launches first-of-its-kind zirconia recycling project for dental waste
By IPP Bureau - May 28, 2026
Under the new initiative, each company takes on a defined role across the recycling chain
Gandhar Oil posts robust FY26 profit
By IPP Bureau - May 28, 2026
PAT soars 201%, EBITDA up 88% on strong PHPO demand & margin expansion
Morepen Labs posts strong Q4 FY26 net profit
By IPP Bureau - May 28, 2026
For the full year, standalone gross revenue crossed Rs. 1,700 crore
Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD
By IPP Bureau - May 28, 2026
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
Quotient Sciences advances AI-designed drug product into Phase I clinical study
By IPP Bureau - May 28, 2026
Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development.
Ashish Mukkirwar appointed CFO of Jubilant Pharmova
By IPP Bureau - May 27, 2026
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
Glenmark Pharma appoints Shisher Chowksey as Head of Marketing
By IPP Bureau - May 27, 2026
In his new role, Shisher will lead Glenmark’s marketing initiatives, focusing on strengthening brand positioning, driving market expansion, and accelerating growth
Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz
By IPP Bureau - May 27, 2026
The company highlighted continued demand strength and pricing resilience despite global disruptions
Novo Nordisk study exposes “hidden” inflammation driving cardio risk despite care
By IPP Bureau - May 27, 2026
POSEIDON is among the largest global datasets to quantify this residual inflammatory burden
Tecan launches direct India operations
By IPP Bureau - May 27, 2026
The move signals a major expansion milestone for the Swiss laboratory automation company
